bluebird bio Inc - Company Profile
Powered by
All the data and insights you need on bluebird bio Inc in one report.
- Save hours of research time and resources with
our up-to-date bluebird bio Inc Strategy Report
- Understand bluebird bio Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
bluebird bio Inc (bluebird bio) develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on its integrated product platforms comprising gene therapy, cancer immunotherapy and gene editing.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s R&D focuses on the development of betibeglogene autotemcel, elivaldogene autotemcel, and lovo-cel for SCD. It also focuses on the research and discovery of product candidates using its gene editing technology platform. In FY2022, the company spent US$$240.8 million and has 199 employees working on its R&D activities. As of March 8, 2023, the company has eight U.S. patents, seven patent for drug product manufacturing and LVV, 115 patents and 21 patents or five patents issued by U.S. patents related to LVV platform. The company also entered into Research Development Foundation (RDF) for 31 U.S. and foreign patents and patent applications.
Other Break-up
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer